文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

州强制脓毒症流程化诊疗与脓毒症成人患者住院死亡率的相关性

Association Between State-Mandated Protocolized Sepsis Care and In-hospital Mortality Among Adults With Sepsis.
PubMed 文献 · JAMA · 2019-01-01
一句话结论纽约州强制脓毒症流程化诊疗实施后,脓毒症30天住院死亡率相对对照州显著下降,第10季度调整后绝对死亡率降低3.2%。

该回顾性队列研究纳入2011年1月1日至2015年9月30日纽约州及4个对照州(佛罗里达、马里兰、马萨诸塞、新泽西)成人脓毒症住院患者共1 012 410例,覆盖509家医院。研究比较2013年纽约州脓毒症法规实施前后脓毒症30天住院死亡率变化,采用比较中断时间序列分析。调整患者和医院特征及法规实施前时间趋势和季节后,纽约州相对对照州死亡率显著下降(P=0.02),第10季度调整后绝对死亡率较预期降低3.2%(95%CI 1.0%至5.4%,P=0.004)。法规与ICU入住率无显著差异(P=0.09),与住院时间相对降低(P=0.04)、艰难梭菌感染率相对降低(P<0.001)、中心静脉导管使用相对增加(P=0.02)相关。作者指出因纽约州与对照州基线死亡率不同,这些发现是否可推广至其他州尚不确定。

要点

  • 纽约州强制脓毒症流程化诊疗实施后,第10季度调整后绝对死亡率较预期降低3.2%(95%CI 1.0%至5.4%,P=0.004),相对对照州显著下降(P=0.02)。
  • 法规实施后纽约州艰难梭菌感染率第10季度调整后差异为-1.8%(95%CI -2.6%至-1.0%,P<0.001),相对对照州显著降低。
  • 法规实施后中心静脉导管使用第10季度调整后差异为4.8%(95%CI 2.3%至7.4%,P<0.001),相对对照州显著增加。
  • 法规与ICU入住率无显著差异(第10季度调整后差异2.8%[95%CI -1.7%至7.2%],P=0.22)。
  • 作者指出因纽约州与对照州基线死亡率不同,这些发现是否可推广至其他州尚不确定。

适用人群与场景

  • 纽约州及4个对照州(佛罗里达、马里兰、马萨诸塞、新泽西)成人脓毒症住院患者,数据来自全支付方医院出院数据,时间为2011年1月1日至2015年9月30日。
  • 纳入分析共1 012 410例脓毒症住院,覆盖509家医院;平均年龄69.5岁(SD 16.4岁),女性占47.9%。

研究设计与关键结果

  • 研究类型为回顾性队列研究,采用比较中断时间序列分析,比较纽约州2013年脓毒症法规实施前(2011年1月1日至2013年3月31日)与实施后(2013年4月1日至2015年9月30日)的脓毒症住院结局,并与4个未实施脓毒症法规的对照州比较。
  • 纽约州实施前脓毒症住院139 019例、实施后186 767例;对照州实施前289 225例、实施后397 399例。
  • 未调整30天住院死亡率:纽约州实施前26.3%、实施后22.0%;对照州实施前22.0%、实施后19.1%。
  • 调整患者和医院特征及法规实施前时间趋势和季节后,纽约州相对对照州死亡率显著下降(P=0.02,比较中断时间序列估计的联合检验)。
  • 第10季度调整后绝对死亡率纽约州较预期降低3.2%(95%CI 1.0%至5.4%,P=0.004)。
  • ICU入住率无显著差异(P=0.09;第10季度调整后差异2.8%[95%CI -1.7%至7.2%],P=0.22)。
  • 住院时间相对降低(P=0.04;第10季度调整后差异0.50天[95%CI -0.47至1.47天],P=0.31)。
  • 艰难梭菌感染率相对降低(P<0.001;第10季度调整后差异-1.8%[95%CI -2.6%至-1.0%],P<0.001);中心静脉导管使用相对增加(P=0.02;第10季度调整后差异4.8%[95%CI 2.3%至7.4%],P<0.001)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究,采用比较中断时间序列分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,纽约州强制脓毒症流程化诊疗与对照州相比,脓毒症死亡率下降幅度更大。
  • 作者指出,因纽约州与对照州基线死亡率不同,这些发现是否可推广至其他州尚不确定。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Beginning in 2013, New York State implemented regulations mandating that hospitals implement evidence-based protocols for sepsis management, as well as report data on protocol adherence and clinical outcomes to the state government. The association between these mandates and sepsis outcomes is unknown.

OBJECTIVE: To evaluate the association between New York State sepsis regulations and the outcomes of patients hospitalized with sepsis.

DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of adult patients hospitalized with sepsis in New York State and in 4 control states (Florida, Maryland, Massachusetts, and New Jersey) using all-payer hospital discharge data (January 1, 2011-September 30, 2015) and a comparative interrupted time series analytic approach.

EXPOSURES: Hospitalization for sepsis before (January 1, 2011-March 31, 2013) vs after (April 1, 2013-September 30, 2015) implementation of the 2013 New York State sepsis regulations.

MAIN OUTCOMES AND MEASURES: The primary outcome was 30-day in-hospital mortality. Secondary outcomes were intensive care unit admission rates, central venous catheter use, Clostridium difficile infection rates, and hospital length of stay.

RESULTS: The final analysis included 1 012 410 sepsis admissions to 509 hospitals. The mean age was 69.5 years (SD, 16.4 years) and 47.9% were female. In New York State and in the control states, 139 019 and 289 225 patients, respectively, were admitted before implementation of the sepsis regulations and 186 767 and 397 399 patients, respectively, were admitted after implementation of the sepsis regulations. Unadjusted 30-day in-hospital mortality was 26.3% in New York State and 22.0% in the control states before the regulations, and was 22.0% in New York State and 19.1% in the control states after the regulations. Adjusting for patient and hospital characteristics as well as preregulation temporal trends and season, mortality after implementation of the regulations decreased significantly in New York State relative to the control states (P = .02 for the joint test of the comparative interrupted time series estimates). For example, by the 10th quarter after implementation of the regulations, adjusted absolute mortality was 3.2% (95% CI, 1.0% to 5.4%) lower than expected in New York State relative to the control states (P = .004). The regulations were associated with no significant differences in intensive care unit admission rates (P = .09) (10th quarter adjusted difference, 2.8% [95% CI, -1.7% to 7.2%], P = .22), a significant relative decrease in hospital length of stay (P = .04) (10th quarter adjusted difference, 0.50 days [95% CI, -0.47 to 1.47 days], P = .31), a significant relative decrease in the C difficile infection rate (P < .001) (10th quarter adjusted difference, -1.8% [95% CI, -2.6% to -1.0%], P < .001), and a significant relative increase in central venous catheter use (P = .02) (10th quarter adjusted difference, 4.8% [95% CI, 2.3% to 7.4%], P < .001).

CONCLUSIONS AND RELEVANCE: In New York State, mandated protocolized sepsis care was associated with a greater decrease in sepsis mortality compared with sepsis mortality in control states that did not implement sepsis regulations. Because baseline mortality rates differed between New York and comparison states, it is uncertain whether these findings are generalizable to other states.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Kahn JM, Davis BS, Yabes JG, et al. Association Between State-Mandated Protocolized Sepsis Care and In-hospital Mortality Among Adults With Sepsis. JAMA. 2019. PMID: 31310298. doi:10.1001/jama.2019.9021

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。